Find a specialist
Find a specialist
hero patient
hero patient
real patient real patient

Find a specialist

Find a specialist

hero text

EGRIFTA SV
reduces HARD BELLY

(excess visceral abdominal fat)

bottle

Ask your healthcare provider if
EGRIFTA SV™ may be right for you

What is “HARD BELLY”?

HARd BELLY is a buildup of extra hard fat in the abdominal (belly) area. HARD BELLY is different from regular fat.

Find out about HARD BELLY
EGRIFTA SV™ is an FDA approved treatment* used to reduce excess abdominal fat.

It has been proven to significantly reduce HARD BELLY (excess visceral abdominal fat).

Learn more
THERA patient support® provides personal service to help you make the most of therapy.

The Staff Nurses and Patient Care Coordinators are your go-to resources for everyday support.

See the benefits
EGRIFTA SV™ is not approved to reduce the health consequences of HARD BELLY (excess visceral abdominal fat).
*An approved strength of tesamorelin for injection with the same efficacy and safety of tesamorelin 1 mg/vial. The 2 mg/vial is more concentrated than the 1 mg/vial, and the recommended daily dose is 1.4 mg.